(Q71168927)
Statements
Phase 1 study of combination therapy with L-697,661 and zidovudine. The ACTG 184 Protocol Team (English)
Campbell TB
Kuritzkes DR
Blaschke T
Stein DS
Rosandich ME
Phair J
Pottage JC
Messari F
Collier A